Clinical utility of neurofilament light chain as a biomarker for disease onset and progression in hereditary transthyretin amyloidosis

BackgroundNeurofilament light chain levels (NfL) have emerged as a biomarker for early diagnosis and follow-up of hereditary transthyretin variant amyloidosis (ATTRv). We evaluated the most accurate technique for NfL quantifying in ATTRv healthy carriers and symptomatic patients in real-life practic...

詳細記述

書誌詳細

主要な著者:	Álvaro Gragera-Martínez, Cristina Borrachero Garro, Francisco Muñoz Beamud, Ana Manovel Sánchez, Andrés González Macías, Mariano Pizarro Sánchez, Amelia Jiménez Heffernan, Ana Serrano Mira, Beatriz Macías Dominguez, Sandra Garcia Garrido
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2025-10-01
シリーズ:	Frontiers in Neurology
主題:	neurofilament ELISA SiMoA transthyretin amyloidosis ATTRv
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1660344/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!